DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Osteolytic lesion
Osteolytic lesion
RANKL Acts Directly on RANK-Expressing Prostate Tumor Cells and Mediates Migration and Expression of Tumor Metastasis Genes
Effect of Denosumab on Osteolytic Lesion Activity After Total Hip Arthroplasty: a Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Trial
Bone Metastasis
Inhibiting the Osteocyte Specific Protein Sclerostin Increases Bone Mass and Fracture Resistance in Multiple Myeloma
Incidence of Bisphosphonate-Related Osteonecrosis of the Jaw in Consideration of Primary Diseases and Concomitant Therapies
The Role of Osteoblasts in Bone Metastasis
Targeted Overexpression of BSP in Osteoclasts Promotes Bone Metastasis of Breast Cancer Cells
Paradoxical Stress Fracture in a Patient with Multiple Myeloma and Bisphosphonate Use
Radiological Evaluation of the Efficacy of Denosumab As a Treatment For
© Ferrata Storti Foundation
Bone Metabolism in Langerhans Cell Histiocytosis
Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous Versus Extraosseous Breast Tumor Growth in Vivo
Off-Label Uses of Denosumab in Metabolic Bone Diseases T ⁎ Stergios A
Specific Bone Region Localization of Osteolytic Versus Osteoblastic Lesions in a Patient- Derived Xenograft Model of Bone Metastatic Prostate Cancer
A C-Fms Tyrosine Kinase Inhibitor, Ki20227, Suppresses Osteoclast Differentiation and Osteolytic Bone Destruction in a Bone Metastasis Model
Basigin-2 Upregulated by Receptor Activator of NF-Κb Ligand Enhances
The Activity of Zoledronic Acid on Neuroblastoma Bone Metastasis Involves Inhibition of Osteoclasts and Tumor Cell Survival and Proliferation
Lenalidomide Inhibits Osteoclastogenesis, Survival Factors and Bone-Remodeling Markers in Multiple Myeloma
Top View
The Role of Turmeric As an Adjuvant Therapeutic for Osteolytic Breast Cancer Bone Metastases
Multiple Myeloma Associated Bone Disease
Bisphosphonate Guidelines for Treatment and Prevention Of
Denosumab in the Treatment of Bone Metastases
Bisphosphonates in Multiple Myeloma (Review)
Zoledronic Acid: Clinical Potential Beyond the Prevention of Skeletal Complications in Patients with Cancer
Osteolytic Lesions (Brown Tumors) of Primary Hyperparathyroidism Misdiagnosed As Multifocal Giant Cell Tumor of the Distal Ulna and Radius: a Case Report A
RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases